*All agenda times are in US Pacific Time Zone (PT)
Patent litigation is continuously in flux and incredibly complex. The demands of litigation require an effective strategy to remain consistent as the litigation landscape changes due to an uncertain environment. The economic downturn added more layers which resulted in growth in certain areas of IP litigation while other areas such as operating company litigation remained constant. On the defense side, organizations have sought to revise their strategies due to the rising cost of litigation, while still maintaining the freedom to develop and launch innovative new products. Plaintiffs, on the other hand, have proven to be savvy, battle-tested, and ready to use international forums. Practitioners need to exercise caution on using PTAB proceedings while keeping an eye out for NPE litigation in other regions of the world.
This panel will explore:
Technology companies generally understand the value of having a strong IP portfolio, including market advantages and enhanced return on investment, however, understanding what makes an IP portfolio “strong” is often more nebulous. In this session we will discuss what makes an IP portfolio “strong” and will explore strategies for building a business-focused IP strategy that is cost effective and protects the aspects that bring actual value to the company.
While there have been substantial improvements made in the profession of law around diversity – patent law still struggles to attract Diverse talent. While this is part of a bigger issue around STEM, the impact of increasing diversity in STEM fields will be profound. It is also well known that there is a diversity patent gap. What is our role in encouraging diverse innovators so that we as a society can make real progress on bridging the patent gap? Clearly much more can be done.
This session will explore:
No matter which side of the fence you are on, the PTAB is here to stay. In 2020, the PTAB received more than 1,300 petitions, issuing a similar number of institution decisions and nearly 500 final written decisions. As a result, the dynamic has been permanently changed as it relates to patent application, drafting, prosecution, licensing, and enforcement strategies. Patent owners can be reassured, however, that institution rates are decreasing as compared to previous years. Devising an IPR strategy is key when considering co-pending district litigation and the PTAB’s continual discretionary denial practice. In addition, pending leadership at the USPTO adds to the complexity of PTAB proceedings. There is a strong need to continuously reshape the plan as the PTAB appears to be more efficient and consistent.
This panel will explore:
It has been ten years since the enactment of the America Invents Act (AIA). AIA proceedings quickly became a patent smashing success for would-be patent challengers. But over time, patent owners pushed back. Procedures changed moving the pendulum back in the direction of patent owners. In fact, some of the more recent changes have the non-intended consequence of providing advantage to non-practicing entities. Was that what AIA intended? What is next?
This presentation will explore:
Now, maybe more than ever, it is important to take the forum in which a patent suit is pending into account when you plan and implement your patent litigation strategies. The matrix of options and considerations can become quite complicated, particularly when you weave venue transfer and inter partes review possibilities into the equation. We will interview Alex Hadjis, who most recently obtained a defense verdict for Roku in the first jury trial in the Waco Division of the Western District of Texas before Judge Albright, about his experience handling complex patent cases in different venues throughout the United States. The discussion will touch on:
In this 45-minute information packed and supercharged panel, we will cover the very latest on protecting innovation that pushes the patent eligibility boundaries worldwide, including AI, software, digital health and diagnostic and therapeutic methods. We’ll be asking leading in-house voices how best to take local law and practice into account when implementing an international filing strategy, and we’ll be asking private practice attorneys for guidance on how to navigate software and medical exclusions both at the USPTO and EPO. We'll be challenging the panellists to give pragmatic advice, and exploring how today’s best practices in one jurisdiction can help (or hinder!) best practice in other jurisdictions. The discussion will dive into typical stumbling blocks when filing applications for borderline technologies when first filing domestically and nationalising in Europe and elsewhere.
Just as important as domestic U.S. trademarks, international trademarks and brand protection is increasingly necessary for businesses of any size. Since business knows no boundaries, your brand and your trademark portfolio should similarly know no boundaries. Do not be mistaken in believing business stops at the border.
Your business name, logo, and overall brand is how people will identify with your goods and services, so you want to have one, clear identity. That identity and brand should be shared and viewed consistently around the world to the greatest extent possible.
Join Victoria Friedman, Managing Partner for Dennemeyer & Associates US in a discussion around best practices for filing your foreign Trademarks. Victoria will cover topics of translations and transliterations, Madrid protocol and what happens after filing.
With growing complexity in the United States' IP landscape many US companies are looking at international IP strategy to enhance the company’s business goals. For example, in the two biggest markets for the majority of US companies, China and Europe, there are multiple developments to stay on top of. In China the development of a more balanced approach to IP litigation is making it an essential market for US companies. With Europe the turmoil of Brexit and recent changes to the EPO have US companies needing to understand where that leaves them in terms of strategy.
This panel will explore: